At Surge Pharmaceuticals, our Quality Unit emphasizes science-based and risk-based approaches in product development, fostering continuous improvement throughout the product lifecycle. This proactive approach ensures that our processes and products remain aligned with the latest advancements in quality and regulatory standards.

We are dedicated to exceeding customer expectations by leveraging a highly skilled and motivated workforce. Our commitment is to deliver products of the highest standards by adhering to SISPQE principles (Strength, Identity, Safety, Purity, Quality, Efficacy). This is achieved through ongoing employee training programs and strict adherence to a robust quality management system.

Our team consistently embraces new technologies and applies knowledge gained from commercial manufacturing through statistical evaluation and risk-based Quality Risk Management (QRM) principles. Both prospective and retrospective evaluations are conducted to enhance process performance and elevate cGMP standards.

Our key focus is on ensuring timely delivery of products without compromising quality. This is achieved through rigorous quality control processes and adherence to evolving regulatory standards. We maintain a culture of accountability and improvement by conducting periodic reviews with senior management, ensuring strategic alignment with the latest industry practices.
By embedding continual improvement into our quality system, we reaffirm our commitment to delivering safe, effective, and reliable healthcare solutions that meet and exceed global regulatory expectations.